BibleTools
verse

(e.g. john 8 32)
  or  

Mark 7:33  (American Standard Version)
version

A.F.V
A.S.V.
Amplified®
I.S.V.
K.J.V.
N.A.S.B.
NASB E-Prime
Young's


Compare all


Book Notes
   Barnes' Book Notes
   Jamieson, Fausset, and Brown Book Notes
   Robertson's Book Notes (NT)
Commentaries
   Adam Clarke
   Barnes' Notes
   Forerunner Commentary
   Jamieson, Fausset, and Brown
   John Wesley's Notes
   Matthew Henry
   People's Commentary (NT)
   Robertson's Word Pictures (NT)
   Scofield
Definitions
Interlinear
Library
Topical Studies
X-References
Commentaries:
Robertson's Word Pictures (NT)
<< Mark 7:32   Mark 7:34 >>


Mark 7:33

Took him aside (apolabomenov auton). The secrecy here observed was partly to avoid excitement and partly to get the attention of the deaf and dumb demoniac. He could not hear what Jesus said. So Jesus put his fingers into his ears, spat, and touched his tongue. There was, of course, no virtue in the spittle and it is not clear why Jesus used it. Saliva was by some regarded as remedial and was used by exorcists in their incantations. Whether this was a concession to the man's denseness one does not know. But it all showed the poor man that Jesus healed him in his own way.




Other Robertson's Word Pictures (NT) entries containing Mark 7:33:

Mark 8:23
John 9:6

 

<< Mark 7:32   Mark 7:34 >>

DISCLAIMER: Church of the Great God (CGG) provides these resources to aid the individual in studying the Bible. However, it is up to the individual to "prove all things, and hold fast to that which is good" (I Thessalonians 5:21). The content of these resources does not necessarily reflect the views of CGG. They are provided for information purposes only.

Start Your Day with Scripture

Begin each morning with God's Word — the Berean delivers a daily verse and insightful commentary to spark reflection and growth.

Join 140,000+ fellow believers on this journey.

Free and spam-free — unsubscribe anytime.

Leave this field empty
©Copyright 1992-2026 Church of the Great God.   Contact C.G.G. if you have questions or comments.
Close
E-mail This Page